States Hold Sway on Device Sterilization Access

ARTICLE SUMMARY:

While FDA, and the US Environmental Protection Agency, are apparently closely collaborating to balance concerns of ethylene oxide emissions from device sterilization and the growing risk of device shortages, it is the state governments that really have the leverage on this issue and must be engaged.

FDA held an advisory panel meeting November 6-7 to address growing concerns of device shortages in the wake of ethylene oxide (EtO) sterilization facility shutdowns. But there was one important voice that was missing from the panel discussion: state governments.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: